Company Comparison
Evelo Biosciences vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Evelo Biosciences | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Lagos, Nigeria |
| Founded | 2014 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $260M | $45M |
| Valuation | — | — |
What They Build
Evelo Biosciences
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Evelo Biosciences
Sector Overlap
Both Evelo Biosciences and 54gene operate in Biotech.
Browse all Biotech companies →The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.